Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1High-Dose Dexamethasone Combined with Orelabrutinib
(D12160)
[2] Dexamethasone,
Orelabrutinib
[4] Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate ,
Orelabrutinib (D12160) 💬
[2] BTK,
NR3C1 💬
[8] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[1] 63 💬
2Orelabrutinib
(D12160)
[1] Orelabrutinib[1] Orelabrutinib (D12160) 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[5] 13, 49, 53, 61, 63 💬
3Orelabrutinib (High Dose)
(D12160)
[1] Orelabrutinib[1] Orelabrutinib (D12160) 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[1] 49 💬
4Orelabrutinib (Low Dose)
(D12160)
[1] Orelabrutinib[1] Orelabrutinib (D12160) 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[1] 49 💬
5Orelabrutinib( higher dose)
(D12160)
[1] Orelabrutinib[1] Orelabrutinib (D12160) 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[1] 63 💬
6Orelabrutinib( lower dose)
(D12160)
[1] Orelabrutinib[1] Orelabrutinib (D12160) 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[1] 63 💬
7Orelabrutinib-100
(D12160)
[1] Orelabrutinib[1] Orelabrutinib (D12160) 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[1] 61 💬
8Orelabrutinib-150
(D12160)
[1] Orelabrutinib[1] Orelabrutinib (D12160) 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[1] 61 💬
9Orelabrutinib-50
(D12160)
[1] Orelabrutinib[1] Orelabrutinib (D12160) 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[1] 61 💬